Research Report on China in-Vitro Diagnostic Reagent Industry

Oct, 14, 2016, Mumbai, India: Market Reports on China presents the report, on “Research Report on China In-vitro Diagnostic Reagent Industry, 2017-2021”.   In terms of industry regulatory policies, laws and regulations together with industry policies concerning China in-vitro diagnostic industry are gradually consistent with international conventions.

In-vitro diagnostics is a diagnostic method through detecting samples (blood, body fluid, tissues, etc.) taken out from human bodies so as to judge diseases and organism functions. In most cases, the detection system composed of detection instruments and reagents are applied in in-vitro diagnostics. "http://www.marketreportsonchina.com/life-sciences-market-research-reports-23757/research-china-in-vitro-diagnostic-reagent-industry.html"

In-vitro diagnostic reagents are used to carry out in-vitro detection on human samples. In Chinese market, there are mainly three categories including biochemical diagnostic reagents, immune diagnostic reagents and molecule diagnostic reagents.

The global in-vitro diagnostic market is mature and the concentration rate is high. Top 5 manufacturers of global in-vitro diagnostic industry are Roche, Siemens, JNJ, Abbott and Beckman with an aggregate market share of over 60% in the globe as monopolies. The market size of in-vitro diagnostics is closely related to the population base, medical treatment expenses per capita, medical care level and medical technology together with service levels of a country. At present, the demand market of global in-vitro diagnostics is mainly distributed in developed economies such as North America, Europe and Japan.

Meanwhile, emerging economies such as China, India and Brazil are increasing in medical care investment and medical treatment expenses per capita in recent years with large population base and high economic growth rate, leading to the pull for in-vitro diagnostic market demand.

The history of China in-vitro diagnostic industry is...